Neha Pagidipati
Associate Professor of Medicine
Neha J. Pagidipati, MD, MPH, is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science.
Dr. Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity. The program’s multi-disciplinary team of cardiologists, endocrinologists, nephrologists, and hepatologists will work together to provide coordinated, team-based care to the most high-risk and complex patients in the health system.
Dr. Pagidipati’s research grants include the COORDINATE-Diabetes Trial, to improve the quality of care for patients with diabetes and cardiovascular disease across the U.S., and QuBBD: Deep Poisson Methods for Biomedical Time-to-Event and Longitudinal Data. She served as a study clinician on the large, longitudinal EXSCEL (Exenatide Study of Cardiovascular Event Lowering) trial. She is currently conducting a nation-wide study of obesity management using real-world data sources, and is a site investigator for the Baseline Health Study in collaboration with Verily Life Sciences. In addition, she is leading a large study within the Duke Health System to study heterogeneity within cardiovascular disease risk and response to weight loss interventions among individuals with obesity.
Dr. Pagidipati graduated from Harvard College and Harvard Medical School. She completed her internal medicine residency at Brigham and Women’s Hospital. During a two-year research fellowship in Global Women’s Health at the Brigham, she obtained an MPH from the Harvard School of Public Health and studied cardiovascular disease prevention in women in India. Dr. Pagidipati completed a four-year cardiology fellowship at the Duke University School of Medicine and served as Chief Research Fellow at the Duke Clinical Research Institute. In 2017, she became a faculty member of the Duke University School of Medicine School.
Current Appointments & Affiliations
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 2022
- Member of the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2017
Contact Information
- Background
-
Education, Training, & Certifications
- Cardiology Fellowship, Medicine, Duke University School of Medicine 2013 - 2017
- Global Women's Health Fellowship, Brigham and Women's Hospital 2011 - 2013
- M.P.H., Harvard University 2013
- Intership and Residency in Internal Medicine, Brigham and Women's Hospital 2008 - 2011
- M.D., Harvard Medical School 2008
-
Previous Appointments & Affiliations
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2021 - 2022
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2017 - 2020
- Research
-
Selected Grants
- NOVA-LATAM Lipid Management - Industry awarded by Novartis Farmaceutica SA de CV 2022 - 2024
- BI - CKD PHSR Study awarded by Boehringer Ingelheim Corporation 2021 - 2023
- Dissemination and Implementation Science in Cardiovascular Outcomes (DISCO) awarded by National Institutes of Health 2017 - 2023
- ASCVD EHR Cohort - CardioHealth Alliance Project awarded by Novartis Pharmaceuticals Corporation 2022 - 2023
- PHENO (BI Heart Failure Implementation Project ) awarded by Boehringer Ingelheim Corporation 2021 - 2023
- LEADER Trial: Association between weight change and cardiometabolic risk factors in a real-world population of U.S. Adults awarded by Novo Nordisk, Inc. 2019 - 2022
- Landscape Analysis -BI US CKD Study awarded by Boehringer Ingelheim Pharmaceuticals, Inc. 2022
- ATHERO Alliance Learning Lab awarded by NOVARTIS DE COLOMBIA S.A. 2022
- Data Characterization of DUHS data for Amgen project awarded by Amgen, Inc. 2019 - 2021
- Characterization of Lp(a) Testing in a Network Consortium awarded by Amgen, Inc. 2020 - 2021
- QuBBD: Deep Poisson Methods for Biomedical Time-to-Event and Longitudinal Data awarded by National Institutes of Health 2017 - 2021
- Cardiovascular Risk Profile of LAL Deficiency Patients awarded by Alexion Pharmaceuticals, Inc. 2016 - 2020
-
External Relationships
- Amgen, Inc.
- AstraZeneca
- Baseline LLC
- Boehringer Ingelheim/Lilly alliance
- Boehringer Ingleheim
- Crispr Therapeutics
- Merck
- Novartis pharmaceuticals
- Novo Nordisk
- Regeneron Pharmaceuticals
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Gaziano, Thomas A., and Neha Pagidipati. Scaling up chronic disease prevention interventions in lower- and middle-income countries. Vol. 34, 2013. https://doi.org/10.1146/annurev-publhealth-031912-114402.Full Text Link to Item
-
-
Academic Articles
-
Nelson, Adam J., Neha J. Pagidipati, Michelle D. Kelsey, Maddalena Ardissino, Vanita R. Aroda, Matthew A. Cavender, Renato D. Lopes, et al. “Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.” American Heart Journal 256 (February 2023): 2–12. https://doi.org/10.1016/j.ahj.2022.10.079.Full Text
-
Pagidipati, Neha J., and Eric D. Peterson. “Can System Solutions Be Scaled to Control High Blood Pressure and Lipids?” Jama Cardiol 8, no. 1 (January 1, 2023): 21–22. https://doi.org/10.1001/jamacardio.2022.4015.Full Text Link to Item
-
Shah, Nishant P., Courtney Page, Cynthia L. Green, Michael Gao, Joanna Cavalier, Robert W. McGarrah, Tracy A. DeWald, Devdutta Sangvai, Manesh R. Patel, and Neha J. Pagidipati. “Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients.” Am J Cardiol 186 (January 1, 2023): 91–99. https://doi.org/10.1016/j.amjcard.2022.10.033.Full Text Link to Item
-
Nanna, Michael G., Adam J. Nelson, Kevin Haynes, Sonali Shambhu, Zubin Eapen, Mark J. Cziraky, Sara B. Calvert, Neha J. Pagidipati, and Christopher B. Granger. “Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease.” J Am Geriatr Soc, December 20, 2022. https://doi.org/10.1111/jgs.18172.Full Text Link to Item
-
Nelson, Adam J., Neha J. Pagidipati, and Christopher B. Granger. “Reply: High-Dose Statins Increase Adverse Events and Do Not Improve Survival.” J Am Coll Cardiol 80, no. 16 (October 18, 2022): e127. https://doi.org/10.1016/j.jacc.2022.08.741.Full Text Link to Item
-
Grant, Jelani K., Sarah Snow, Michelle Kelsey, Jennifer Rymer, Anna E. Schaffer, Manesh R. Patel, Robert W. McGarrah, Neha J. Pagidipati, and Nishant P. Shah. “Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.” Curr Cardiol Rep 24, no. 10 (October 2022): 1373–85. https://doi.org/10.1007/s11886-022-01751-z.Full Text Link to Item
-
Nelson, Adam J., Josephine L. Harrington, Ahmed A. Kolkailah, Neha J. Pagidipati, and Darren K. McGuire. “Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events.” Heart Fail Clin 18, no. 4 (October 2022): 597–607. https://doi.org/10.1016/j.hfc.2022.03.007.Full Text Link to Item
-
O’Toole, Thomas, Michelle D. Kelsey, Nishant P. Shah, Robert W. McGarrah, and Neha J. Pagidipati. “Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.” Curr Cardiol Rep 24, no. 10 (October 2022): 1397–1406. https://doi.org/10.1007/s11886-022-01760-y.Full Text Link to Item
-
Lumsden, Rebecca H., and Neha Pagidipati. “Management of cardiovascular risk factors during pregnancy.” Heart 108, no. 18 (August 25, 2022): 1438–44. https://doi.org/10.1136/heartjnl-2021-319606.Full Text Link to Item
-
Chatterjee, Ranee, Lydia Coulter Kwee, Neha Pagidipati, Lynne H. Koweek, Priyatham S. Mettu, Francois Haddad, David J. Maron, et al. “Multi-dimensional characterization of prediabetes in the Project Baseline Health Study.” Cardiovasc Diabetol 21, no. 1 (July 18, 2022): 134. https://doi.org/10.1186/s12933-022-01565-x.Full Text Link to Item
-
Goldstein, Sarah A., and Neha J. Pagidipati. “Hypertensive Disorders of Pregnancy and Heart Failure Risk.” Curr Hypertens Rep 24, no. 7 (July 2022): 205–13. https://doi.org/10.1007/s11906-022-01189-2.Full Text Link to Item
-
Kelsey, Michelle D., Adam J. Nelson, Jennifer B. Green, Christopher B. Granger, Eric D. Peterson, Darren K. McGuire, and Neha J. Pagidipati. “Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.” J Am Coll Cardiol 79, no. 18 (May 10, 2022): 1849–57. https://doi.org/10.1016/j.jacc.2022.02.046.Full Text Link to Item
-
Lowenstern, Angela, Karen P. Alexander, Neha J. Pagidipati, C Larry Hill, Patricia A. Pellikka, Lawton S. Cooper, Brooke Alhanti, Udo Hoffmann, Daniel B. Mark, and Pamela S. Douglas. “Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial.” Circ Cardiovasc Qual Outcomes 15, no. 5 (May 2022): e008298. https://doi.org/10.1161/CIRCOUTCOMES.121.008298.Full Text Link to Item
-
Nelson, Adam J., Kevin Haynes, Sonali Shambhu, Zubin Eapen, Mark J. Cziraky, Michael G. Nanna, Sara B. Calvert, Kerrin Gallagher, Neha J. Pagidipati, and Christopher B. Granger. “High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.” Journal of the American College of Cardiology 79, no. 18 (May 2022): 1802–13. https://doi.org/10.1016/j.jacc.2022.02.048.Full Text
-
Sata, Suchita Shah, Susan E. Spratt, Daniel L. Edmonston, and Neha Pagidipati. “Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.” J Hosp Med 17, no. 5 (May 2022): 360–63. https://doi.org/10.1002/jhm.12798.Full Text Link to Item
-
White, Harvey D., Gregory G. Schwartz, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Chern-En Chiang, Rafael Diaz, et al. “Alirocumab after acute coronary syndrome in patients with a history of heart failure.” Eur Heart J 43, no. 16 (April 19, 2022): 1554–65. https://doi.org/10.1093/eurheartj/ehab804.Full Text Link to Item
-
Nelson, Adam J., Emily C. O’Brien, Lisa A. Kaltenbach, Jennifer B. Green, Renato D. Lopes, Caryn G. Morse, Hussein R. Al-Khalidi, et al. “Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.” Jama Netw Open 5, no. 2 (February 1, 2022): e2148030. https://doi.org/10.1001/jamanetworkopen.2021.48030.Full Text Link to Item
-
Rao, Vishal N., Michelle D. Kelsey, Michael A. Blazing, Neha J. Pagidipati, Terry A. Fortin, and Marat Fudim. “Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make.” Circ Heart Fail 15, no. 2 (February 2022): e008982. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008982.Full Text Link to Item
-
Kolossváry, Márton, Thomas Mayrhofer, Maros Ferencik, Júlia Karády, Neha J. Pagidipati, Svati H. Shah, Michael G. Nanna, et al. “Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial.” J Cardiovasc Comput Tomogr 16, no. 5 (2022): 397–403. https://doi.org/10.1016/j.jcct.2022.03.006.Full Text Link to Item
-
Pagidipati, Neha J., Matthew Phelan, Courtney Page, Megan Clowse, Ricardo Henao, Eric D. Peterson, and Benjamin A. Goldstein. “The importance of weight stabilization amongst those with overweight or obesity: Results from a large health care system.” Prev Med Rep 24 (December 2021): 101615. https://doi.org/10.1016/j.pmedr.2021.101615.Full Text Link to Item
-
Samsky, Marc D., Robert J. Mentz, Amanda Stebbins, Yuliya Lokhnygina, Aaron W. Aday, Neha J. Pagidipati, W Schuyler Jones, et al. “Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.” Atherosclerosis 338 (December 2021): 1–6. https://doi.org/10.1016/j.atherosclerosis.2021.10.011.Full Text
-
Rao, Vishal N., Evan Murray, Javed Butler, Lauren B. Cooper, Zachary L. Cox, Mona Fiuzat, Jennifer B. Green, et al. “In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 78, no. 20 (November 16, 2021): 2004–12. https://doi.org/10.1016/j.jacc.2021.08.064.Full Text Link to Item
-
Taron, Jana, Borek Foldyna, Thomas Mayrhofer, Michael T. Osborne, Nandini Meyersohn, Daniel O. Bittner, Stefan B. Puchner, et al. “Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease.” Jacc Cardiovasc Imaging 14, no. 11 (November 2021): 2186–95. https://doi.org/10.1016/j.jcmg.2021.03.019.Full Text Link to Item
-
Kelsey, Michelle, and Neha Pagidipati. “Towards a personalised approach for obesity treatment: one size does not fit all.” Heart 107, no. 19 (October 2021): 1526–27. https://doi.org/10.1136/heartjnl-2021-319726.Full Text Link to Item
-
McGuire, Darren K., and Neha J. Pagidipati. “GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs.” Lancet Diabetes Endocrinol 9, no. 10 (October 2021): 640–41. https://doi.org/10.1016/S2213-8587(21)00212-6.Full Text Link to Item
-
Weissler, E Hope, Robert M. Clare, Yuliya Lokhnygina, John B. Buse, Shaun G. Goodman, Brian Katona, Nayyar Iqbal, et al. “Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.” Diabet Med 38, no. 10 (October 2021): e14552. https://doi.org/10.1111/dme.14552.Full Text Link to Item
-
Pagidipati, Neha J., and Eric D. Peterson. “Should Cardiovascular Preventive Therapy Be Over-the-Counter?” J Am Coll Cardiol 78, no. 11 (September 14, 2021): 1124–26. https://doi.org/10.1016/j.jacc.2021.07.020.Full Text Link to Item
-
Barbery, Carlos E., Anna Giczewska, Jennifer White, Yuliya Lokhnygina, Robert John Mentz, Rury R. Holman, Neha Pagidipati, Adrian F. Hernandez, and W Schuyler Jones. “Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus.” American Heart Journal 239 (September 2021): 59–63. https://doi.org/10.1016/j.ahj.2021.03.013.Full Text
-
Pagidipati, Neha J., and Prakash Deedwania. “A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.” Am J Med 134, no. 9 (September 2021): 1076–84. https://doi.org/10.1016/j.amjmed.2021.04.024.Full Text Link to Item
-
Kelsey, Michelle, Courtney Page, Brooke Alhanti, Shannon L. Rhodes, Shia T. Kent, Eric Peterson, and Neha Pagidipati. “Lipoprotein(a) Testing Patterns in a Large Health System.” Am J Cardiol 153 (August 15, 2021): 43–50. https://doi.org/10.1016/j.amjcard.2021.05.018.Full Text Link to Item
-
Nelson, Adam J., Neha J. Pagidipati, Vanita R. Aroda, Matthew A. Cavender, Jennifer B. Green, Renato D. Lopes, Hussein Al-Khalidi, et al. “Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.” Circulation 144, no. 1 (July 6, 2021): 74–84. https://doi.org/10.1161/CIRCULATIONAHA.121.053766.Full Text Link to Item
-
Pagidipati, Neha J., and Laura P. Svetkey. “Time for a Renewed Focus on the DASH-Low Sodium Diet.” J Am Coll Cardiol 77, no. 21 (June 1, 2021): 2635–37. https://doi.org/10.1016/j.jacc.2021.03.323.Full Text Link to Item
-
Nelson, Adam J., Neha J. Pagidipati, and Christopher B. Granger. “The SAMSON trial: using a placebo to improve medication tolerability.” Eur Heart J Cardiovasc Pharmacother 7, no. 3 (May 23, 2021): e13. https://doi.org/10.1093/ehjcvp/pvab017.Full Text Link to Item
-
Kammerlander, Andreas A., Thomas Mayrhofer, Maros Ferencik, Neha J. Pagidipati, Julia Karady, Geoffrey S. Ginsburg, Michael T. Lu, et al. “Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain.” Diabetes Care 44, no. 4 (April 2021): 1038–45. https://doi.org/10.2337/dc20-1760.Full Text Link to Item
-
Nelson, Adam J., Maddalena Ardissino, Kevin Haynes, Sonali Shambhu, Zubin J. Eapen, Darren K. McGuire, Anthony Carnicelli, et al. “Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease.” J Am Heart Assoc 10, no. 2 (January 19, 2021): e016835. https://doi.org/10.1161/JAHA.120.016835.Full Text Link to Item
-
Wosik, Jedrek, Megan E. B. Clowse, Robert Overton, Bhargav Adagarla, Nicoleta Economou-Zavlanos, Joanna Cavalier, Ricardo Henao, et al. “Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care.” Am Heart J 231 (January 2021): 1–5. https://doi.org/10.1016/j.ahj.2020.10.074.Full Text Link to Item
-
Bihlmeyer, Nathan A., Lydia Coulter Kwee, Clary B. Clish, Amy Anderson Deik, Robert E. Gerszten, Neha J. Pagidipati, Blandine Laferrère, et al. “Metabolomic profiling identifies complex lipid species and amino acid analogues associated with response to weight loss interventions.” Plos One 16, no. 5 (January 2021): e0240764. https://doi.org/10.1371/journal.pone.0240764.Full Text
-
Zeitouni, Michel, Robert M. Clare, Karen Chiswell, Jawan Abdulrahim, Nishant Shah, Neha P. Pagidipati, Svati H. Shah, Matthew T. Roe, Manesh R. Patel, and W Schuyler Jones. “Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease.” J Am Heart Assoc 9, no. 24 (December 15, 2020): e017712. https://doi.org/10.1161/JAHA.120.017712.Full Text Link to Item
-
Ellison, Stephen, Jawan W. Abdulrahim, Lydia Coulter Kwee, Nathan A. Bihlmeyer, Neha Pagidipati, Robert McGarrah, James R. Bain, William E. Kraus, and Svati H. Shah. “Novel plasma biomarkers improve discrimination of metabolic health independent of weight.” Sci Rep 10, no. 1 (December 7, 2020): 21365. https://doi.org/10.1038/s41598-020-78478-w.Full Text Link to Item
-
Blumer, Vanessa, and Neha J. Pagidipati. “Hypertensive Disorders of Pregnancy and Long-Term Heart Failure Risk: A Missed Opportunity for Prevention.” Hypertension 76, no. 5 (November 2020): 1420–22. https://doi.org/10.1161/HYPERTENSIONAHA.120.15924.Full Text Link to Item
-
Nelson, Adam J., Ann Marie Navar, Hillary Mulder, Daniel Wojdyla, Sephy Philip, Craig Granowitz, Eric D. Peterson, and Neha J. Pagidipati. “Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial).” Am J Cardiol 132 (October 1, 2020): 36–43. https://doi.org/10.1016/j.amjcard.2020.07.005.Full Text Link to Item
-
Carnicelli, Anthony P., Robert Clare, Karen Chiswell, Barbara Lytle, Magnus Bjursell, Shira Perl, Karolina Andersson, et al. “Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.” Am J Cardiol 127 (July 15, 2020): 64–72. https://doi.org/10.1016/j.amjcard.2020.04.026.Full Text Link to Item
-
Pathak, P., N. Pagidipati, S. M. Clancy, G. Sharma, and T. Ostbye. “Park Quality and Road Walkability in Greater Noida, India: A Case Study Demonstrating GIS for Assessing Barriers to Being Physically Active in Urban Areas.” International Journal of Applied Geospatial Research 11, no. 3 (July 1, 2020): 24–47. https://doi.org/10.4018/IJAGR.2020070103.Full Text
-
Armstrong, Sarah C., McAllister Windom, Nathan A. Bihlmeyer, Jennifer S. Li, Svati H. Shah, Mary Story, Nancy Zucker, et al. “Rationale and design of "Hearts & Parks": study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity.” Bmc Pediatr 20, no. 1 (June 26, 2020): 308. https://doi.org/10.1186/s12887-020-02190-x.Full Text Link to Item
-
Gao, Yumin, Eric Peterson, and Neha Pagidipati. “Barriers to prescribing glucose-lowering therapies with cardiometabolic benefits.” Am Heart J 224 (June 2020): 47–53. https://doi.org/10.1016/j.ahj.2020.03.017.Full Text Link to Item
-
Lumsden, Rebecca H., Neha J. Pagidipati, Matthew P. Phelan, Karen Chiswell, and Eric D. Peterson. “Prevalence and Management of Adult Obesity in a Large U.S. Academic Health System.” Am J Prev Med 58, no. 6 (June 2020): 817–24. https://doi.org/10.1016/j.amepre.2020.01.018.Full Text Link to Item
-
Böhm, Michael, Kazuomi Kario, David E. Kandzari, Felix Mahfoud, Michael A. Weber, Roland E. Schmieder, Konstantinos Tsioufis, et al. “Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.” Lancet 395, no. 10234 (May 2, 2020): 1444–51. https://doi.org/10.1016/S0140-6736(20)30554-7.Full Text Link to Item
-
Goyal, Akash, Neha Pagidipati, C Larry Hill, Brooke Alhanti, James E. Udelson, Michael H. Picard, Patricia A. Pellikka, Udo Hoffmann, Daniel B. Mark, and Pamela S. Douglas. “Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.” Circ Cardiovasc Imaging 13, no. 4 (April 2020): e009986. https://doi.org/10.1161/CIRCIMAGING.119.009986.Full Text Link to Item
-
Truby, Lauren K., Christopher O’Connor, Mona Fiuzat, Amanda Stebbins, Adrian Coles, Chetan B. Patel, Bradi Granger, et al. “Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure: Insights From the PAL-HF Trial.” Circ Heart Fail 13, no. 4 (April 2020): e006134. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006134.Full Text Link to Item
-
Sharma, Abhinav, Neha J. Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave Demets, Jyothis Thomas George, et al. “Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.” Circulation 141, no. 10 (March 10, 2020): 843–62. https://doi.org/10.1161/CIRCULATIONAHA.119.041022.Full Text Link to Item
-
Farmer, Heather R., Linda A. Wray, Ying Xian, Hanzhang Xu, Neha Pagidipati, Eric D. Peterson, and Matthew E. Dupre. “Racial Differences in Elevated C-Reactive Protein Among US Older Adults.” J Am Geriatr Soc 68, no. 2 (February 2020): 362–69. https://doi.org/10.1111/jgs.16187.Full Text Link to Item
-
Litwin, Sheldon E., Adrian Coles, C Larry Hill, Brooke Alhanti, Neha Pagidipati, Kerry L. Lee, Patricia A. Pellikka, et al. “Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.” Heart 106, no. 4 (February 2020): 273–79. https://doi.org/10.1136/heartjnl-2018-314503.Full Text Link to Item
-
Reed, Shelby D., Yanhong Li, Helen A. Dakin, Frauke Becker, Jose Leal, Stephanie M. Gustavson, Bernt Kartman, et al. “Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).” Diabetes Care 43, no. 2 (February 2020): 374–81. https://doi.org/10.2337/dc19-0950.Full Text Link to Item
-
Aberra, Tsion, Eric D. Peterson, Neha J. Pagidipati, Hillary Mulder, Daniel M. Wojdyla, Sephy Philip, Craig Granowitz, and Ann Marie Navar. “The association between triglycerides and incident cardiovascular disease: What is "optimal"?” J Clin Lipidol 14, no. 4 (2020): 438-447.e3. https://doi.org/10.1016/j.jacl.2020.04.009.Full Text Link to Item
-
Pagidipati, Neha J., Yinggan Zheng, Jennifer B. Green, Darren K. McGuire, Robert J. Mentz, Svati Shah, Pablo Aschner, et al. “Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.” Am Heart J 219 (January 2020): 47–57. https://doi.org/10.1016/j.ahj.2019.09.016.Full Text Link to Item
-
Badjatiya, Anish, Peter Merrill, John B. Buse, Shaun G. Goodman, Brian Katona, Nayyar Iqbal, Neha J. Pagidipati, et al. “Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial.” Circ Cardiovasc Interv 12, no. 12 (December 2019): e008018. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008018.Full Text Link to Item
-
Bhatt, Ankeet S., Nancy Luo, Nicole Solomon, Neha J. Pagidipati, Giuseppe Ambrosio, Jennifer B. Green, Darren K. McGuire, et al. “International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.” Am Heart J 218 (December 2019): 57–65. https://doi.org/10.1016/j.ahj.2019.08.016.Full Text Link to Item
-
Goldstein, Benjamin A., Matthew Phelan, Neha J. Pagidipati, and Sarah B. Peskoe. “How and when informative visit processes can bias inference when using electronic health records data for clinical research.” J Am Med Inform Assoc 26, no. 12 (December 1, 2019): 1609–17. https://doi.org/10.1093/jamia/ocz148.Full Text Link to Item
-
Fudim, Marat, Jennifer White, Neha J. Pagidipati, Yuliya Lokhnygina, Julio Wainstein, Jan Murin, Nayyar Iqbal, et al. “Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.” Circulation 140, no. 20 (November 12, 2019): 1613–22. https://doi.org/10.1161/CIRCULATIONAHA.119.041659.Full Text Link to Item
-
Gao, Yumin, Eric Peterson, and Neha Pagidipati. “Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease.” Clin Cardiol 42, no. 11 (November 2019): 1063–70. https://doi.org/10.1002/clc.23252.Full Text Link to Item
-
Pagidipati, Neha J., and Renato D. Lopes. “New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?” J Thorac Cardiovasc Surg 158, no. 4 (October 2019): 1113–17. https://doi.org/10.1016/j.jtcvs.2019.03.140.Full Text Link to Item
-
Granger, Christopher B., Adam J. Nelson, and Neha J. Pagidipati. “Risk of Total Events With Icosapent Ethyl: Can We Reduce It?” Journal of the American College of Cardiology 73, no. 22 (June 2019): 2803–5. https://doi.org/10.1016/j.jacc.2019.03.492.Full Text
-
Goldstein, Benjamin A., Matthew Phelan, Neha J. Pagidipati, Rury R. Holman, Michael J. Pencina, and Elizabeth A. Stuart. “An outcome model approach to transporting a randomized controlled trial results to a target population.” J Am Med Inform Assoc 26, no. 5 (May 1, 2019): 429–37. https://doi.org/10.1093/jamia/ocy188.Full Text Link to Item
-
Setji, Tracy L., Courtney Page, Neha Pagidipati, and Benjamin A. Goldstein. “DIFFERENCES IN ACHIEVING HBA1C GOALS AMONG PATIENTS SEEN BY ENDOCRINOLOGISTS AND PRIMARY CARE PROVIDERS.” Endocr Pract 25, no. 5 (May 2019): 461–69. https://doi.org/10.4158/EP-2018-0405.Full Text Link to Item
-
Sharma, Abhinav, Adrian Coles, Nishant K. Sekaran, Neha J. Pagidipati, Michael T. Lu, Daniel B. Mark, Kerry L. Lee, Hussein R. Al-Khalidi, Udo Hoffmann, and Pamela S. Douglas. “Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.” J Am Coll Cardiol 73, no. 8 (March 5, 2019): 893–902. https://doi.org/10.1016/j.jacc.2018.11.056.Full Text Link to Item
-
Christopher, Bridgette A., and Neha J. Pagidipati. “Clinical Updates in Women's Health Care Summary: Evaluation and Management of Lipid Disorders: Primary and Preventive Care Review.” Obstet Gynecol 133, no. 3 (March 2019): 609. https://doi.org/10.1097/AOG.0000000000003139.Full Text Link to Item
-
Pagidipati, Neha J., Adrian Coles, Kshipra Hemal, Kerry L. Lee, Rowena J. Dolor, Patricia A. Pellikka, Daniel B. Mark, et al. “Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial.” Am Heart J 208 (February 2019): 28–36. https://doi.org/10.1016/j.ahj.2018.11.002.Full Text Link to Item
-
Litwin, Sheldon E., Adrian Coles, Neha Pagidipati, Kerry L. Lee, Patricia A. Pellikka, Daniel B. Mark, James E. Udelson, Udo Hoffmann, Pamela S. Douglas, and Pamela S. PROMISE Investigators. “Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial.” J Cardiovasc Comput Tomogr 13, no. 4 (2019): 211–18. https://doi.org/10.1016/j.jcct.2019.03.010.Full Text Link to Item
-
Nelson, Adam J., Eric D. Peterson, and Neha J. Pagidipati. “Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.” Prog Cardiovasc Dis 62, no. 4 (2019): 306–14. https://doi.org/10.1016/j.pcad.2019.07.001.Full Text Link to Item
-
Pagidipati, Neha J., Daniel W. Mudrick, Karen Chiswell, Amanda Brucker, Eric D. Peterson, and Pamela S. Douglas. “Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease.” Am Heart J 206 (December 2018): 51–60. https://doi.org/10.1016/j.ahj.2018.09.014.Full Text Link to Item
-
Robinson, Jennifer G., Kevin Jon Williams, Samuel Gidding, Jan Borén, Ira Tabas, Edward A. Fisher, Chris Packard, et al. “Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.” J Am Heart Assoc 7, no. 20 (October 16, 2018): e009778. https://doi.org/10.1161/JAHA.118.009778.Full Text Link to Item
-
Mentz, Robert J., M Angelyn Bethel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Juliana C. Chan, João S. Felício, et al. “Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.” J Am Heart Assoc 7, no. 19 (October 2, 2018): e009304. https://doi.org/10.1161/JAHA.118.009304.Full Text Open Access Copy Link to Item
-
Pagidipati, Neha J., Anne S. Hellkamp, Puza P. Sharma, Tracy Y. Wang, Gregg C. Fonarow, and Michael Pencina. “High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.” Am Heart J 204 (October 2018): 151–55. https://doi.org/10.1016/j.ahj.2018.07.014.Full Text Link to Item
-
Bhavsar, Nrupen A., Aijing Gao, Matthew Phelan, Neha J. Pagidipati, and Benjamin A. Goldstein. “Value of Neighborhood Socioeconomic Status in Predicting Risk of Outcomes in Studies That Use Electronic Health Record Data.” Jama Netw Open 1, no. 5 (September 7, 2018): e182716. https://doi.org/10.1001/jamanetworkopen.2018.2716.Full Text Link to Item
-
Pagidipati, Neha J., Robert M. Clare, Robert T. Keenan, Karen Chiswell, Matthew T. Roe, and Connie N. Hess. “Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease.” J Am Heart Assoc 7, no. 16 (August 21, 2018): e009328. https://doi.org/10.1161/JAHA.118.009328.Full Text Link to Item
-
Prabhakaran, Dorairaj, Kavita Singh, Gregory A. Roth, Amitava Banerjee, Neha J. Pagidipati, and Mark D. Huffman. “Cardiovascular Diseases in India Compared With the United States.” J Am Coll Cardiol 72, no. 1 (July 3, 2018): 79–95. https://doi.org/10.1016/j.jacc.2018.04.042.Full Text Link to Item
-
Kochar, Ajar, Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia A. Cowper, Matthew T. Roe, Eric D. Peterson, and Tracy Y. Wang. “Long-Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical Practice.” J Am Heart Assoc 7, no. 13 (June 30, 2018). https://doi.org/10.1161/JAHA.117.007230.Full Text Link to Item
-
Bethel, M Angelyn, Rishi A. Patel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Robert J. Mentz, Neha J. Pagidipati, et al. “Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.” Lancet Diabetes Endocrinol 6, no. 2 (February 2018): 105–13. https://doi.org/10.1016/S2213-8587(17)30412-6.Full Text Link to Item
-
Sharma, Abhinav, Nishant K. Sekaran, Adrian Coles, Neha J. Pagidipati, Udo Hoffmann, Daniel B. Mark, Kerry L. Lee, et al. “Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial.” J Am Heart Assoc 6, no. 11 (October 31, 2017). https://doi.org/10.1161/JAHA.117.007019.Full Text Link to Item
-
Holman, Rury R., M Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, Juliana C. Chan, et al. “Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.” N Engl J Med 377, no. 13 (September 28, 2017): 1228–39. https://doi.org/10.1056/NEJMoa1612917.Full Text Link to Item
-
Pagidipati, Neha J., Ann Marie Navar, Karen S. Pieper, Jennifer B. Green, M Angelyn Bethel, Paul W. Armstrong, Robert G. Josse, et al. “Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).” Circulation 136, no. 13 (September 26, 2017): 1193–1203. https://doi.org/10.1161/CIRCULATIONAHA.117.027252.Full Text Link to Item
-
Pagidipati, Neha J., Ann Marie Navar, and Michael J. Pencina. “Guideline Recommendations for Statin Therapy-Reply.” Jama 318, no. 10 (September 12, 2017): 964. https://doi.org/10.1001/jama.2017.11379.Full Text Link to Item
-
Pagidipati, Neha J., Anne Hellkamp, Laine Thomas, Martha Gulati, Eric D. Peterson, and Tracy Y. Wang. “Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.” Jama Cardiol 2, no. 9 (September 1, 2017): 1040–42. https://doi.org/10.1001/jamacardio.2017.2369.Full Text Link to Item
-
Mentz, Robert J., M Angelyn Bethel, Stephanie Gustavson, Vivian P. Thompson, Neha J. Pagidipati, John B. Buse, Juliana C. Chan, et al. “Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).” Am Heart J 187 (May 2017): 1–9. https://doi.org/10.1016/j.ahj.2017.02.005.Full Text Link to Item
-
Pagidipati, Neha J., Connie N. Hess, Robert M. Clare, Axel Akerblom, Pierluigi Tricoci, Daniel Wojdyla, Robert T. Keenan, et al. “An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.” Am Heart J 187 (May 2017): 53–61. https://doi.org/10.1016/j.ahj.2017.02.023.Full Text Link to Item
-
Pagidipati, Neha J., Ann Marie Navar, Hillary Mulder, Allan D. Sniderman, Eric D. Peterson, and Michael J. Pencina. “Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.” Jama 317, no. 15 (April 2017): 1563–67. https://doi.org/10.1001/jama.2017.3416.Full Text
-
Pagidipati, Neha J., and Christopher B. Granger. “Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age.” Ann Intern Med 166, no. 6 (March 21, 2017): JC26. https://doi.org/10.7326/ACPJC-2017-166-6-026.Full Text Link to Item
-
Pagidipati, Neha J., and Pamela S. Douglas. “The Puzzle of Noninvasive Testing in Women: Filling in the Pieces With the CRESCENT Trial (Calcium Imaging and Selective CT Angiography in Comparison to Functional Testing for Suspected Coronary Artery Disease).” Circ Cardiovasc Imaging 10, no. 2 (February 2017). https://doi.org/10.1161/CIRCIMAGING.117.006085.Full Text Link to Item
-
Pagidipati, Neha J., and Eric D. Peterson. “Acute coronary syndromes in women and men.” Nat Rev Cardiol 13, no. 8 (August 2016): 471–80. https://doi.org/10.1038/nrcardio.2016.89.Full Text Link to Item
-
Pagidipati, Neha J., Kshipra Hemal, Adrian Coles, Daniel B. Mark, Rowena J. Dolor, Patricia A. Pellikka, Udo Hoffmann, et al. “Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease.” J Am Coll Cardiol 67, no. 22 (June 7, 2016): 2607–16. https://doi.org/10.1016/j.jacc.2016.03.523.Full Text Link to Item
-
Pagidipati, Neha J., Michael Pencina, and Allan D. Sniderman. “The Enigma of Glucose and Lipid Metabolism.” Jama Cardiol 1, no. 2 (May 1, 2016): 145–46. https://doi.org/10.1001/jamacardio.2016.0183.Full Text Link to Item
-
Hemal, Kshipra, Neha J. Pagidipati, Adrian Coles, Rowena J. Dolor, Daniel B. Mark, Patricia A. Pellikka, Udo Hoffmann, et al. “Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.” Jacc Cardiovasc Imaging 9, no. 4 (April 2016): 337–46. https://doi.org/10.1016/j.jcmg.2016.02.001.Full Text Link to Item
-
Pagidipati, Neha Jadeja, and Thomas A. Gaziano. “Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement.” Circulation 127, no. 6 (February 12, 2013): 749–56. https://doi.org/10.1161/CIRCULATIONAHA.112.128413.Full Text Link to Item
-
Pagidipati, Neha J., Mark D. Huffman, Panniyammakal Jeemon, Rajeev Gupta, Prakash Negi, Thannikot M. Jaison, Satyavan Sharma, et al. “Association between gender, process of care measures, and outcomes in ACS in India: results from the detection and management of coronary heart disease (DEMAT) registry.” Plos One 8, no. 4 (2013): e62061. https://doi.org/10.1371/journal.pone.0062061.Full Text Link to Item
-
Pagidipati, Neha, Keith L. Obstein, Rachel Rucker-Schmidt, Robert D. Odze, and Christopher C. Thompson. “Acute hepatitis due to epstein-barr virus in an immunocompetent patient.” Dig Dis Sci 55, no. 4 (April 2010): 1182–85. https://doi.org/10.1007/s10620-009-0835-z.Full Text Link to Item
-
-
Book Sections
-
Gaziano, T. A., and N. J. Pagidipati. “Global cardiovascular therapy.” In Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease: Fourth Edition, 75–82, 2012. https://doi.org/10.1016/B978-1-4557-0101-8.00006-0.Full Text
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.